XML 97 R80.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements - Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 18, 2020
Dec. 31, 2020
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 09, 2020
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Total impairment loss           $ 199,500,000 $ 377,100,000    
Proceeds from sale of business           558,067,000   $ 1,416,000  
Outstanding debt   $ 466,706,000       466,706,000 1,048,127,000    
Term Loans                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Debt instrument net fair value   463,200,000       463,200,000      
Outstanding debt   466,700,000       466,700,000      
Revolving Credit Facility                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Line of credit   0       0      
Carrying Value                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Cash and cash equivalents   100,400,000       100,400,000      
Nutrisystem, Inc.                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Total impairment loss       $ 199,500,000   199,500,000 [1] 377,100,000 [2]    
Goodwill impairment loss           90,200,000      
Proceeds from sale of business           $ 550,500,000      
Customary indebtedness and cash adjustments                 $ 558,900,000
Carrying value of disposal group             $ 1,088,458,000   585,700,000
Estimated gross proceeds excluding transaction costs                 $ 561,700,000
Nutrisystem, Inc. | Forecast                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Proceeds from sale of business         $ 2,800,000        
Nutrition Business Unit                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Proceeds from sale of business $ 575,000,000.0                
Continuing Operations                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Goodwill impairment loss       0          
Discontinued Operations | Nutrition                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Goodwill impairment loss   $ 24,000,000.0 $ 66,200,000            
SilverSneakers | Continuing Operations | Tradename                  
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]                  
Impairment loss of intangibles       $ 0          
[1]

Results include the period from January 1, 2020 through December 8, 2020.

[2]

Results include the period from March 8, 2019 (the date of acquisition) through December 31, 2019.